WJWM
CASI

Williams Jones Wealth Management’s CASI Pharmaceuticals CASI Stock Holding History

Williams Jones Wealth Management’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,375
Closed -$28K – 424
2020
Q1 		$28K Buy
+1,375
New +$32.8K ﹤0.01% 376

Other funds holding CASI

IACGFIA
IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Williams Jones Wealth Management's CASI Position: Q2 2020 in Review

Williams Jones Wealth Management sold out of CASI Pharmaceuticals (CASI) in Q2 2020, closing a stake of 1,375 shares — an estimated $28K sold.

Williams Jones Wealth Management first reported a position in CASI in Q1 2020 and held it in 1 quarter. The position peaked at $28K in Q1 2020. 59 funds tracked by Wall St. Rank hold CASI as of Q2 2020.

  • Williams Jones Wealth Management reported no remaining CASI Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Williams Jones Wealth Management sold 1,375 CASI Pharmaceuticals shares in Q2 2020, an estimated $28K.
  • Williams Jones Wealth Management first reported a position in CASI Pharmaceuticals in Q1 2020 and held it in 1 quarter.
  • Williams Jones Wealth Management's CASI Pharmaceuticals position peaked at $28K in Q1 2020.
  • 59 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q2 2020.

Based on Williams Jones Wealth Management's 13F filing for Q2 2020, filed 14 Aug 2020.